A ground-breaking gene-editing therapy for sickle cell disease, a debilitating ailment that affects around 100,000 Americans, the majority of whom are people of color (POC), was authorized by the U.S. Food and Drug Administration (FDA) on Friday.
Read More Gene-Editing Treatment For Sickle Cell Anemia Is Approved By FDATag: medication
Supreme Court To Discuss Sackler Family’s $6B Opioid Settlement
The legitimacy of a nearly $6 billion bankruptcy deal involving Purdue Pharma, the maker of the drug OxyContin, which is blamed for sparking the deadly opioid crisis, will be the subject of arguments before the Supreme Court on Monday morning.
Read More Supreme Court To Discuss Sackler Family’s $6B Opioid Settlement